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1. Introduction  
Malaria remains a devastating disease, particularly in the tropics. The annual incidence 
of malaria worldwide is estimated to be between 294 and 500 million clinical cases, while 
estimates of annual mortality from malaria, caused largely by the protozoan Plasmodium 
falciparum, range from 0.97 to 2.7 million worldwide (World Malaria Report 20101, World 
Health Organization; Snow et al., 2005). The emergence of resistance to conventional 
antimalarial drugs and insecticides means that new chemotherapeutic approaches with 
alternative targets are needed (Ridley, 2002). Better understandings of antimalarial drugs 
and the biology of the parasites are needed to allow the development of new 
medications.  
A review of the impact of continuous cultures of P. falciparum underscores their significant 
contributions to malaria research (Trager & Jensen, 1997). The mechanisms responsible for 
the growth of the parasite, however, remain largely unknown. Culture media for P. 
falciparum require human serum, a growth-promoting fraction derived from adult bovine 
plasma (GFS), or lipid-enriched bovine albumin (Asahi & Kanazawa, 1994; Asahi et al., 1996; 
Cranmer et al. 1997; Jensen, 1979). Elucidation of the factors able to induce the growth of P. 
falciparum could be of help, not only for successful culture of the parasite, but also for 
providing critical clues to understanding the biology of parasite proliferation during the 
erythrocytic phase.  
In order to identify the factors controlling parasite development, and the effects of growth-
promoting factors on the parasite, we initially investigated growth-promoting substances to 
formulate a chemically defined culture medium (CDM) suitable for sustaining the complete 
development and intraerythrocytic growth of P. falciparum. We also developed a simple and 
sensitive flow-cytometry-based assay for following each developmental stage of the 
parasite’s erythrocytic growth. The distinct roles of the growth-promoting factors in the 
growth of P. falciparum were then investigated. 
                                                 
1http://www.who.int/malaria/world_malaria_report_2010/en/index.htm  
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2. Parasites and culture 
Cultures of the FCR3/FMG (ATCC Catalogue No. 30932, Gambia) strain of P. falciparum 
were used in all experiments. The parasites were routinely maintained using in vitro culture 
techniques. The culture medium was devoid of whole serum, and consisted of basal 
medium supplemented with 10% GFS (Daigo’s GF21; Wako Pure Chemical Industries, 
Japan), as previously reported (Asahi, 2009; Asahi & Kanazawa, 1994; Asahi et al., 1996; 
Asahi et al., 2005; Asahi et al., 2011). This complete medium is referred to as GFSRPMI. The 
basal medium consisted of RPMI-1640 containing 2 mM glutamine, 25 mM 4-(2-
hydroxylethyl)-piperazine ethanesulfonic acid, 24 mM NaHCO3 (Invitrogen Ltd., USA), 25 
µg/ml gentamycin (Sigma-Aldrich Corp., USA) and 150 µM hypoxanthine (Sigma-Aldrich). 
Briefly, erythrocytes (RBC) were preserved in Alsever’s solution (Sigma-Aldrich; Asahi et 
al., 1996) for 3–30 days. They were then washed, dispensed into 24-well culture plates at a 
hematocrit (% of packed RBC in medium) of 2% (1 ml of suspension/well), and cultured in a 
humidified atmosphere of 5% CO2, 5% O2, and 90% N2 at 37ºC. For subculture, 3-4 days after 
inoculation, infected RBC and uninfected RBC were washed. Parasitemia (% of infected RBC 
in total RBC) was adjusted to 0.1% (for subculture) or 0.4% (for growth tests), by adding 
uninfected RBC, and the hematocrit was adjusted to 2% by adding the appropriate volume 
of either GFSRPMI or the test medium. The cultures were synchronized at the ring stage by 
three successive exposures to 5% (w/v) D-sorbitol (Sigma-Aldrich) at 41- and 46-h intervals. 
After the third sorbitol treatment, residual schizonts and cell debris were removed by 
isopycnic density centrifugation on 63% Percoll PLUS (GE Healthcare Bio-Science Corp., 
USA). The current cultivation method remains essentially the same as initially described 
(Jensen, 2002), with a few refinements, particularly in terms of the culture medium. The 
growth experiments were performed by replacing GFSRPMI with test samples. Growth rate 
was estimated by dividing the parasitemia of the test sample after incubation by the initial 
parasitemia.  
3. CDM for continuous intraerythrocytic growth of P. falciparum using lipids  
The P. falciparum parasite develops through three distinct stages within RBC during its cycle 
of approximately 48 h: ring, trophozoite, and schizont (Bannister et al., 2000). However, the 
development of P. falciparum requires the presence of currently unknown factors present in 
human serum (Jensen, 1979). Although numerous studies have attempted to identify the 
factors and substances able to sustain parasite growth (Asahi & Kanazawa, 1994; Asahi et 
al., 1996, 2005; Cranmer et al., 1997; Divo and Jensen. 1982; Lingnau et al., 1994; Mi-Ichi et 
al., 2006; Nivet et al., 1983; Ofulla et al., 1993; Willet and Canfield, 1984), the establishment of 
a fully-defined culture medium for the parasite has represented a major challenge. We 
previously reported that GFS supported intraerythrocytic growth of P. falciparum (Asahi and 
Kanazawa, 1994; Asahi et. al., 1996; Asahi et al., 2005). GFS contains lipid-rich albumin as a 
major component. Similarly, Cranmer et al. (1997) described a commercially available lipid-
enriched bovine albumin (Albumax II; Invitrogen) that could replace human serum for the 
in vitro cultivation of P. falciparum. These serum substitutes are currently widely employed 
to maintain parasite cultures. However, there is still insufficient information on these 
indispensable additives to allow direct identification of the functional components required 
for the growth of P. falciparum. The replacement of human serum or GFS in culture medium 
with chemically- or functionally-defined substances could not only be advantageous for 
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parasite culture, but could also provide critical clues about the parasite’s biology and its 
requirements for proliferation at the erythrocyte stage. To establish a CDM for continuous, 
intraerythrocytic growth of P. falciparum, we initially characterized the ability of the various 
components of GFS to sustain parasite growth (Asahi et al., 2005). Based on these results, we 
subsequently determined the ability of structurally defined chemicals to sustain parasite 
growth, and formulated a CDM for P. falciparum growth (Asahi, 2009).  
3.1 The ability of GFS components to sustain parasite growth  
We investigated the components of GFS and related substances that have shown an ability 
to sustain parasite growth (Asahi et al., 2005). A simple total lipid fraction of GFS obtained 
by lipid extraction has been shown to sustain complete parasite development. However, 
specific proteins such as bovine and human albumin, as well as the simple total lipid 
fraction of GFS, have also been shown to be important (Figure 1a). The simple total  
lipid fraction of GFS contained phospholipids, diacylglycerides (DAG), cholesterol, 
monoglycerides, nonesterified fatty acids (NEFA) and cholesteryl esters. The components of 
the NEFA fraction were mainly cis-9-octadecenoic acid (C18:1-cis-9, 43%), hexadecanoic acid  
 
Fig. 1. Abilities of fractions derived from GFS (a) and a total simple lipid fraction of GFS (b) 
to sustain growth of P. falciparum. Growth rate was estimated 4 days after inoculation.  
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(C16:0, 21%), octadecanoic acid (C18:0, 14%), cis,cis-9,12-octadecadienoic acid (C18:2), cis-9-
hexadecenoic acid (C16:1), cis-5,8,11,14-eicosatetraenoic acid (C20:4), cis-5,8,11,14,17-
eicosapentaenoic acid (C20:5), and cis-4,7,10,13,16,19-docosahexaenoic acid (C22:6). Each 
NEFA enriched with bovine albumin (fatty-acid free) was tested for its ability to promote 
parasite growth. Mixtures of NEFA, but not individual NEFA, sustained parasite growth to 
a low extent (Figure 1b), but parasite growth in the presence of various combinations of 
NEFA was still lower than that achieved with a simple total lipid fraction of GFS, or with 
GFS- or human serum-containing medium. These results implied that, although the NEFA 
components of the simple total lipid fraction are functional factors in promoting parasite 
growth, other factor (s) must also contribute to the high growth-promoting activity of GFS.  
3.2 CDM for intraerythrocytic growth of P. falciparum 
Initial experiments designed to determine the factor (s) responsible for the high growth-
promoting activity of GFS involved culture of P. falciparum with the lipid classes found in 
the simple total lipid fraction of GFS, and different concentrations of a mixture of the two 
most abundant NEFA, C18:1-cis-9 (0–60 µg/ml [212.4 µM]) and C16:0 (0–30 µg/ml [117.0 
µM]) at a ratio of 2:1. The growth rate was dependent on the concentrations of the NEFA in 
the mixture: the maximum effect was obtained with 30 µg/ml C18:1-cis-9 plus 15 µg/ml 
C16:0, with declines at lower and higher concentrations. However, the growth rates were 
much lower than that obtained with a simple total lipid fraction of GFS or with GFSRPMI.  
A mixture of all the constituents detected in a simple total lipid fraction of GFS sustained 
complete parasite growth. In an attempt to identify the factor (s) responsible for this growth-
promoting effect, each lipid was omitted from the medium in turn. Parasite growth in the 
absence of phosphatidylcholine (PC) decreased to a level similar to that seen with the NEFA 
mixture (Figure 2a). Phospholipids were also tested for their possible efficacies in 
augmenting the ability of NEFA to promote parasite growth, by adding each phospholipid 
to cultures with NEFA. Phospholipids, even PC alone, markedly amplified the growth-
promoting ability of the NEFA mixture (Figure 2b). These results indicate the critical 
importance of PC for amplifying the parasite-growth-promoting ability of NEFA mixtures. 
Phospholipids other than PC, such as phosphatidylethanolamine (PE), phosphatidylserine 
(PS), and phosphatidic acid (PA), were also beneficial for parasite growth, while the growth 
rates in the absence of phosphatidylinositol (PI), cholesterol, and cholesterol ester were 
significantly higher (Figure 2a), indicating these phospholipids were detrimental. DAG had 
no effect on the growth rate of the parasite at the concentrations tested.  
The effects of various types of NEFA mixtures enriched with phospholipids were tested for 
their abilities to promote parasite growth. The growth rate was dependent on the ratios of 
the two NEFA; the highest growth rate occurred at 2:1 (C18:1-cis-9 to C16:0) at a total 
concentration of 45 µg/ml. The growth rates with the best mixtures of NEFA in the presence 
of phospholipids were significantly higher than those with the same NEFA in the absence of 
phospholipids (Figure 3). The culture media were also reconstituted by mixing 
phospholipids with two types of NEFA (either C18:1-cis-9 plus a saturated NEFA or C16:0 
plus an unsaturated NEFA). The best combination of NEFA was C18:1-cis-9 plus C16:0, 
followed by cis-11-octadecenoic acid (C18:1-cis-11) plus C16:0, C18:1-cis-9 plus 
pentadecanoic acid (C15:0), C18:1-cis-9 plus C18:0, and C18:1-cis-9 plus tetradecanoic  
acid (C14:0). The combinations of C16:1 plus C16:0, cis-6-octadecenoic acid (C18:1-cis-6) plus  
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Fig. 2. Effects of various classes of lipids and combinations of phospholipids on abilities of 
NEFA to sustain growth of P. falciparum. The combination of 30 µg/ml C18:1-cis-9 and 15 
µg/ml C16:0 served as a control. Growth rate was estimated 4 days after inoculation.  
C16:0, cis-13-octadecenoic acid (C18:1-cis-13) plus C16:0, and C18:2 plus C16:0 showed 
similar growth-promoting effects to that seen with C18:1-cis-9 plus C16:0 in the absence of 
phospholipids. Combinations of C18:1-cis-9 plus dodecanoic acid (C12:0), C18:1-cis-9 plus 
docosanoic acid (C22:0), cis,cis,cis-6,9,12-octadecatrienoic acid (C18:3) plus C16:0, C20:4 plus 
C16:0, C20:5 plus C16:0, and C22:6 plus C16:0 were detrimental to parasite growth. The 
combination of trans-9-octadecenoic acid (C18:1-trans-9) plus C16:0 also deterred parasite 
growth (Figure 4). The efficacies of NEFA in sustaining the growth of P. falciparum thus 
varied markedly, depending on the type, total amount, and combinations used; saturated or 
unsaturated NEFA with longer or shorter carbon-chain lengths than the optimal 
combination (C18:1-cis-9 plus C16:0) promoted growth to lesser extents, or were detrimental 
to the growth of P. falciparum. Higher degrees of unsaturation were also detrimental to 
parasite growth. The growth-promoting effects of NEFA with 18 carbons and one double 
bond are specific to the cis-form, and the position of the double bond in these NEFA 
influences their growth-promoting effects.  
Various PC containing different fatty acid moieties, such as two of hexanoic acid, C12:0, 
C14:0, C16:0, C18:1, C18:1 in racemic form, C18:2, and C20:4, two different fatty acids of 
C18:1 and C16:0, and C20:4 and C16:0, and PC derived from soy beans and egg yolk, were 
tested at graded concentrations ranging from 20–320 µM, for their abilities to augment the 
effects of the NEFA mixture on parasite growth. Among the 12 tested PC, 1,2-dioleoyl-sn-
glycero-3-phosphocholine (PC-di18:1) markedly amplified the growth-promoting ability of 
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the NEFA mixture in a dose-dependent manner and over a wide range of concentrations, to 
a level similar to that seen with GFSRPMI (Figure 5). This was followed by 1,2-dipalmitoyl-
sn-glycero-3-phosphocholine (PC-di16:0) and 2-oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine 
(PC-18:1/16:0). The addition of PC other than PC-di18:1 at certain concentrations also 
augmented the growth-promoting ability of the NEFA mixture to various extents, ranging 
from 0–270%.  
 
Fig. 3. Growth of P. falciparum with NEFA (C18:1-cis-9 plus C16:0) in the presence ( ) or 
absence ( ) of phospholipids. Growth rate was estimated 4 days after inoculation. #, A 
paired NEFA of C18:1-cis-9 and C16:0 served as a control.  
Specific proteins such as bovine and human albumin were shown to be required for P. 
falciparum growth in serum-free culture with lipids, as stated above. Recombinant human 
albumin could replace serum albumin for sustaining parasite growth in the presence of 
lipids (Figure 6).  
All stages of P. falciparum cultured in the formulated CDM containing the best combination 
of two NEFA, phospholipids, and human, bovine, or recombinant albumin were 
morphologically indistinguishable from growth in complete medium (Figure 7).  
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Fig. 4. Growth of P. falciparum in the presence of various combinations of paired NEFA. Each 
saturated NEFA was added at 15 µg/ml in the presence of 30 µg/ml C18:1-cis-9 (*) and each 
unsaturated NEFA at 30 µg/ml in the presence of 15 µg/ml C16:0 (**). These culture media 
contained phospholipids. #, NEFA (C18:1-cis-9 + C16:0) in the absence of phospholipids 
served as a control. Growth rate was estimated 4 days after inoculation.  
4. Development of a measure of intraerythrocytic growth of P. falciparum 
using flow cytometry and SYBR Green I  
Growth-promoting and antimalarial effects on plasmodia can be assessed both 
quantitatively and qualitatively by directly examining RBC smears from blood or cultures 
under a microscope; however, this method is tedious and subjective. Numerous novel in 
vitro assays have been introduced that are more objective, faster, more sensitive, and 
designed to be easier to handle. The most common of these include isotopic, enzymatic, and 
enzyme-linked immunosorbent assays (ELISA) (Noedl et al., 2003). Isotopic assays rely on 
the incorporation of radioactive 3H-hypoxanthine into the parasite DNA  (Noedl et al., 2003; 
Webster et al., 1985; Yayon et al., 1983). These methods are relatively reliable and objective, 
but not sufficiently sensitive, and require the use of hazardous radioactive material. The 
assays are well suited for screening large numbers of compounds. Parasite lactate 
dehydrogenase levels have also been used to assess the growth of malarial parasites (Asahi, 
et al., 2005; Makler and Hinrichs, 1993; Noedl et al., 2003). ELISA-based assays can provide 
measures of parasite growth by quantifying biomolecules produced during parasite 
development, such as histidine-rich protein 2 or parasite lactate dehydrogenase, by double-
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site sandwich ELISA (Druihe, et al., 2001; Noedl et al., 2002; Noedl et al., 2003). ELISA-based 
tests are rapid and easy to perform, and are also well suited for the screening of large 
number of drugs. These methods have been widely employed to detect and analyze the 
growth of parasites, although they are poorly suited for discriminating the developmental 
stages of the parasite in parasitized RBC. Flow cytometry using nucleic acid staining offers 
the possibility of studying the cell cycle and developmental stages of intraerythrocytic 
growth of malaria parasites. Flow cytometric analysis using intercalating dyes, such as 
acridine orange, thiazole orange, hydroethidine, propidium iodine, YOYO-1, and SYTO-16, 
has already been used successfully to test human and murine samples  (Barkan et al., 2000; 
Janse and Van Vianen, 1994; Jimenez-Diaz et al., 2009; Jouin et al., 1995; Li et al., 2007; 
Nyakeriga, 2004; Persson et al., 2006). However, the use of flow cytometry has been limited 
by its lack of specificity and the complicated preparation required. We modified the flow 
cytometry system and introduced SYBR Green I as an intercalating dye, allowing the growth 
and development of P. falciparum to be analyzed with a high degree of accuracy (Izumiyama 
et al., 2009).  
 
Fig. 5. Effects of various types of PC containing different fatty acid moieties on the abilities 
of NEFA to sustain growth of P. falciparum. Growth rate was estimated 4 days after 
inoculation. #, A paired NEFA of C18:1-cis-9 and C16:0 served as a control.  
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Fig. 6. Effects of various proteins on the ability of a mixture of NEFA and phospholipids to 
sustain growth of P. falciparum. Growth rate was estimated by dividing the parasitemia of 
the test sample 4 days after inoculation by the initial parasitemia.  
Merozoites
 
Schizont
 
Young schizont Trophozoite  Ring form 
 
Fig. 7. Different stages of the parasite cultured in the formulated CDM, stained with Giemsa.  
4.1 Optimization of flow cytometric measurement of infected RBC with SYBR Green I  
The cytometer was equipped with a single argon-ion laser tuned to a fluorescence excitation 
of 488 nm for 15 mW output (PAS flow cytometer, Partec Co. Ltd., Germany). A 
FACSCalibur (Becton Dickinson Immunocytometry Systems, USA) was also used with a 
single fluorescence measurement (530 nm). Analysis was performed using FCS express 
software (De Novo Software Inc., Canada).  
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In order to distinguish infected RBC or merozoites from platelets, leukocytes, and RBC 
debris by flow cytometry, it is essential for them to retain their normal morphological 
characteristics and membrane integrity, without disruption. We evaluated the effects of (1) 
fixatives, (2) dilution buffer and concentration range of SYBR Green I, and (3) staining 
period on the intensity of fluorescence of infected RBC. (1) Infected RBC in culture were 
fixed using fixatives such as 1% paraformaldehyde or 1% glutaraldehyde in Tris-saline 
solution (20 mM Tris (hydroxymethyl) aminomethane hydrochloride at pH 7.2 and 138 mM 
NaCl), phosphate-buffered saline (PBS) (10 mM phosphate buffer at pH 7.2 and 138 mM 
NaCl), or Alsever’s solution. Paraformaldehyde combined with Alsever’s solution proved 
the most useful fixative, with no noticeable lysis or deformity of infected/uninfected RBC, 
such as often occurs when Tris-saline or PBS is used to dilute fixatives. (2) Concentration 
ranges and dilution buffers for SYBR Green I were tested to determine the optimal solution 
for producing clearly resolved peaks of fluorescence. Individual peaks in histograms 
corresponding to the development stages of infected RBC showed most clearly with SYBR 
Green I diluted at concentrations ranging from 0.00625–2× in Tris-saline at pH 8.8 (SYBR 
Green I-basic). Both fixed and unfixed infected RBC gave the best results at 1× dilution of 
SYBR Green I. (3) The dependence of fluorescence with time for fixed or unfixed infected 
RBC in SYBR Green I-basic at 1× dilution was evaluated over 30 min by time-curve analysis 
of P. falciparum cultures. The frequency distribution of fluorescence was similar after 
staining for 5 min or longer with SYBR Green I-basic, although fluorescence could be 
detected within seconds after addition of the fluorescent stain to fixed or unfixed infected 
RBC. SYBR Green I in Tris-saline at pH 6.8 and PBS resulted in inadequate signals for 
infected RBC stained for less than 30 min, and in deformation and hemolysis of infected 
RBC. Accordingly, the optimized protocol was fixation of infected/uninfected RBC by the 
addition of 1% paraformaldehyde combined with Alsever’s solution, and staining the fixed 
RBC, at measure by flow cytometry, by adding into SYBR Green I-basic solution containing 
SYBR Green I at x1 dilution for 5 min.  
4.2 Visualization of infected RBC populations with SYBR Green I-basic  
Infected RBC populations were stained as described above. All developmental stages were 
clearly stained with SYBR Green I with no autofluorescence of RBC (Figure 8).  
ring form trophozoite schizont segmenter merozoite 
 
Fig. 8. Developmental stages of P. falciparum stained with SYBR Green I-basic.  
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Infected RBC were stained with SYBR Green I-basic by adding 8 x 105 cells into 1 ml staining 
solution, followed by analysis with flow cytometry. SYBR Green I-basic provided brilliant 
resolution of infected versus uninfected RBC and permitted visualization of infected RBC 
populations with high accuracy. Infected RBC were located as three clusters in two-
parameter dot-plot presentations of infected/uninfected RBC from P. falciparum cultures: (1) 
cluster 1 (C1) contained predominantly ring forms with low DNA content (low fluorescence 
intensity); (2) cluster 2 (C2) contained predominantly late trophozoites and young schizonts 
with moderate DNA content (moderate fluorescence intensity); and (3) cluster 3 (C3) 
contained late schizonts and segmenters with high DNA content (high fluorescence 
intensity) (Figures 9a, b).  
In regular cultures, schizonts burst spontaneously to release free merozoites, which then 
enter new RBC and increase the number of infected RBC. While the majority of released free 
merozoites remain in culture for a while, the merozoites after culture indicate the 
completion of schizogony. Parasites were synchronized at the ring form stage and cultured 
over 45 h under the pressure of various concentrations of the anti-schizogony drug 
chloroquine, to confirm the accuracy of counting the number of merozoites by flow 
cytometry. Merozoites released from mature schizonts were counted clearly and sensitively 
by flow cytometry (Figures 10a,b).  
 
Fig. 9. Two-parameter dot-plot representation of fluorescent units and side scatter from 
asynchronous culture (a) of P. falciparum and schizont-rich populations (b) separated by 
Percoll sedimentation.  
www.intechopen.com
 
Malaria Parasites 
 
84 
 
Fig. 10. Merozoites released into surrounding medium were counted (a) and the number of 
merozoites decreased under the pressure of graded concentrations of chloroquine (b). The 
numbers of merozoites are shown per 5,000 infected RBC (b).  
5. Differing effects of NEFA and phospholipids on intraerythrocytic growth of 
P. falciparum in serum-free medium  
The efficacies of NEFA in sustaining general growth of P. falciparum varied markedly, 
depending on the type, total amount, and combinations. Certain structural characteristics of 
NEFA, such as carbon-chain length, degree and position of unsaturation, and isomerism 
were important. However, the mechanisms responsible for the different abilities of the 
various NEFA in the presence or absence of phospholipids, and of specific proteins such as 
bovine and human albumin for promoting parasite growth are unknown. Subsequent 
experiments therefore investigated the distinct effects of various NEFA on each 
developmental stage of P. falciparum, including schizogony, merozoite formation, and 
reinvasion of RBC, to provide clues to the mechanisms underlying the growth-promoting 
properties of NEFA.  
5.1 Four typical growth patterns  
To assess the effects of NEFA on each developmental stage of the parasite (schizogony, 
merozoite formation, and reinvasion of RBC), synchronized P. falciparum were cultured in 
the presence of phospholipids and bovine albumin, further supplemented with one or two 
NEFA. The distribution of the parasites among the different developmental stages was 
determined using flow cytometry with SYBR Green I-basic at 25 and 45 h during the first 
cycle of growth (Izumiyama et al., 2009). Late schizonts at 25 h (schizont-25h), released 
merozoites at 45 h (released merozoite-45h), new ring forms at 45 h (ring form-45h), and 
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parasitemia at 45 h (parasitemia-45h) were compared between parasites grown under test 
conditions and those grown in complete medium GFSRPMI. Different types and 
combinations of NEFA exerted markedly distinct effects on parasite growth in the 
presence/absence of phospholipids. Four typical growth patterns were defined: no 
inhibition (comparable to growth in complete medium); and three rate-determining steps in 
growth including suppressed schizogony (SS); suppressed formation of merozoites (SMF); 
and inhibited invasion of merozoites into new RBC (IMI)/formation of incomplete 
merozoites (Figure 11).  
 
Fig. 11. Representative modification of growth of P. falciparum cultured synchronously in the 
presence of various growth promoters, indicating comparable growth, SS, SMF, and IMI. 
Each developmental stage was compared with complete growth in GFSRPMI (control): ring 
forms (—○—), late schizonts (…▲…), parasitemia (—X—), and released merozoites (closed 
bars). Parasites at the ring stage (adjusted to 5.0% parasitemia) were maintained in different 
culture media.  
5.2 Growth-rate-determining steps in development of P. falciparum cultured in various 
growth factors  
All stages of the parasite cultured in medium supplemented with NEFA (C18:1-cis-9 plus 
C16:0) in the presence of phospholipids were comparable to those grown in GFSRPMI. 
Medium containing C18:1-cis-9 and C12:0 caused parasites to accumulate in clusters of ring 
forms, by an SS effect. SS was also observed in the presence of C16:0 alone, C18:2 plus C16:0, 
C20:4 plus C16:0, or C18:1-trans-9 plus C16:0. Partial SS (less suppressed) was detected when 
the mixture of C18:1-cis-13 plus C16:0 was added. C18:1-cis-9 alone and C18:1-cis-9 plus 
C22:0 suppressed the progression of parasites to merozoites following schizont formation, 
by an SMF effect. SMF was also observed in parasites cultured in C18:1-cis-9 plus C16:0 in 
the absence of phospholipids, indicating that exogenous phospholipids were crucial for the 
development of complete merozoites. Adding C18:1-cis-13 plus C16:0 or C16:1 plus C16:0 to 
the media caused accumulation of the merozoites released from mature schizonts, but the 
merozoites did not invade new RBC, by the IMI effect. Partial IMI (less inhibited) was 
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detected when C18:1-cis-9 plus C14:0, C18:1-cis-6 plus C16:0, C18:1-cis-11 plus C16:0, or 
C18:1-cis-9 plus C18:0 were added. Any effects on steps that governed parasite growth rate 
disrupted the cyclic behavior of the parasite, and reduced parasitemia at 45 h culture. These 
results indicate that different NEFA exert distinct roles in parasite development by arresting 
development at different stages (Figure 12).  
NEFA 
Growth-rate 
determining step 
Growth level 
Ring --- Trophozoite --- Schizont --- Merozoite --- New ring 
C18:1-cis-9 SMF 
C18:1-cis-9+C12:0 SS 
C18:1-cis-9+C14:0 partial IMI 
C18:1-cis-6+C16:0 partial IMI 
C18:1-cis-9+C16:0 
comparable/ 
better 
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Fig. 12. Growth-rate-determining step and growth level in development of P. falciparum 
cultured in the presence of NEFA alone or in combination. Growth of the parasite was 
examined in the presence of optimal phospholipids, except for C18:1-cis-9 plus C16:0 in the 
absence of phospholipids (*) and GFSRPMI. Bovine albumin was added to the medium, 
except for GFSRPMI.  
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5.3 Microscopic examination of P. falciparum cultured with NEFA exerting IMI and 
SMF effects  
Microscopic examination revealed that parasites cultured in medium containing NEFA 
(C18:1-cis-9 plus C16:0), phospholipids and bovine albumin closely resembled parasites 
grown in GFSRPMI. In contrast, the majority of ring forms cultured in media containing 
C16:1 plus C16:0 or C18:1-cis-13 plus C16:0 (IMI effect) for 45 h were devoid of normal 
structures. The majority of schizonts cultured in media containing C18:1-cis-9 alone, C18:1-
cis-9 plus C22:0, C18:1-cis-9 plus C16:0 in the absence of phospholipids (SMF effect) for 45 h 
were found to be degenerate (Figure 13).  
Schizonts 
Ring forms 
Normal Abnormal 
 
Fig. 13. Abnormal parasites (ring forms and schizonts) grown in non-optimal culture media.  
6. Conclusions and future perspectives  
In an attempt to elucidate the mechanisms responsible for growth of P. falciparum, growth-
promoting factors were identified and a CDM suitable for complete growth of the parasite 
was established. The CDM consists of paired NEFA, phospholipids with specific fatty acid 
moieties, and specific proteins dissolved in basal medium RPMI1640 supplemented with 
hypoxanthine. The most effective combination of NEFA was C18:1-cis-9 and C16:0. The best 
phospholipid crucial for serum-free culture medium supplemented with NEFA was PC-
di18:1 at concentrations of 80–320 µg/ml. A simple protocol for flow cytometry with SYBR 
Green I was developed and used to analyze the various developmental stages of P. 
falciparum. Different stages of the parasite in RBC and released merozoites were quantified 
using this flow cytometry protocol. These techniques were applied to investigate the distinct 
roles of the identified growth-promoting factors in the development of the parasite, 
demonstrating that different combinations of NEFA and phospholipids exerted distinct 
roles in the growth of P. falciparum by sustaining development at different stages.  
These findings can be usefully applied in diverse aspects malaria research, including drug 
resistance, vaccine development, genetics, parasite biochemistry, and studies of the 
relationship between the parasites and the host RBC. Culture in CDM produces similar 
results to those using the original culture method with human serum (Trager & Jensen, 
1997), with the added advantage of avoiding the adverse effects caused by human serum. In 
particular, the methods reported here will allow the components crucial to each 
developmental stage of the parasite to be established. We have already performed a large-
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scale analysis of the genome-wide gene expression in P. falciparum cultured in the various 
CDM established here, to investigate the relationship between gene expression regulation 
and parasite development at different stages. This comprehensive analysis identified a 
number of genes possibly involved in arresting parasite development. These results will be 
reported elsewhere. Interactions between growth-promoting factors and parasite 
components can provide critical clues to the understanding of the general biology of P. 
falciparum, and will provide the foundations for future drug and vaccine development 
efforts aimed at eradicating this disease.  
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